Join
Live feed
·
INSIDERFilingvia Quantisnow
Spruce Biosciences Inc. logo

Interim Chief Medical Officer Ways Douglas Kirk converted options into 1,250 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SPRB· Spruce Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SPRB (Spruce Biosciences Inc.) and more on Quantisnow.